MannKind Corporation to Hold 2025 Second Quarter Financial Results Conference Call on August 6, 2025

Core Viewpoint - MannKind Corporation is set to release its second quarter 2025 financial results on August 6, 2025, before market open [1] Group 1: Financial Results Announcement - The financial results will be discussed in a webcast starting at 9:00 a.m. Eastern Time on the same day [2] - The webcast will be accessible via MannKind's investor relations website, with a replay available for approximately 90 days [2] Group 2: Company Overview - MannKind Corporation focuses on developing and commercializing innovative inhaled therapeutic products and devices for serious unmet medical needs, particularly in endocrine and orphan lung diseases [3] - The company aims to alleviate the burden of diseases such as diabetes, nontuberculous mycobacterial lung disease, pulmonary fibrosis, and pulmonary hypertension through its advanced formulation and device engineering capabilities [4] - MannKind's technologies include dry-powder formulations and inhalation devices that enable rapid and convenient delivery of medications to the lungs [4]